Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs

Anesthesiology

Volumn 104, Issue 5, 2006, Pages 1015-1022

  Kang, Jiesheng ^a   Reynolds, William P ^a   Chen, Xiao Liang ^a   Ji, Junzhi ^a   Wang, Hongge ^a   Rampe, David E ^a,b  

^a Sanofi Aventis US Inc   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL L TYPE; DOFETILIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV4.3; SEVOFLURANE; SODIUM CHANNEL; SOTALOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHANNEL GATING; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; GUINEA PIG; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; INHALATION ANESTHESIA; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION;

ACTION POTENTIALS; ADRENERGIC BETA-ANTAGONISTS; ANESTHETICS, INHALATION; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CELL SEPARATION; CHO CELLS; CRICETINAE; DRUG INTERACTIONS; GUINEA PIGS; HUMANS; ION CHANNELS; LONG QT SYNDROME; METHYL ETHERS; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PHENETHYLAMINES; SOTALOL; SULFONAMIDES;

EID: 33646821702     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200605000-00018     Document Type: Article

References (41)

1. Ben-David J, Zipes DP: Torsades de pointes and proarrhythmia. Lancet 1993; 341:1578-82
2. Sanguinetti MC, Jiang C, Curran ME, Keating MT: A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995; 81:299-307
3. Pearlstein R, Vaz R, Rampe D: Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel: A model for bad behavior. J Med Chem 2003; 46:2019-22
4. Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palenthorpe S, Siegl PKS, Strang I, Sullivan AT, Wallis R, Camm AJ, Hammond: Relationship between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsades de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardiovasc Res 2003; 58:32-45
5. Kang J, Chen X-L, Wang L, Rampe D: Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG. J Pharmacol Exp Ther 2001; 299:290-6
6. Ficker E, Kuryshev YA, Dennis AT, Obejero-Paz C, Wang L, Hawryluk P, Wible BA, Brown AM: Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol 2004; 66:33-44
7. Kuryshev YA, Ficker E, Wang L, Hawryluk P, Dennis AT, Wible BA, Brown AM, Kang J, Chen X-L, Sawamura K, Reynolds W, Rampe D: Pentamidine-induced long QT syndrome and block of HERG trafficking. J Pharmacol Exp Ther 2005; 312:316-23
8. Loeckinger A, Kleinsasser A, Maier S, Furtner B, Keller C, Kuehbacher G, Lindner KH: Sustained prolongation of the QTc interval after anesthesia with sevoflurane in infants during the first six months of life. ANESTHESIOLOGY 2003; 98:639-42
9. Whyte-Simon D, Booker PD, Buckley DG: The effects of propofol and sevoflurane on the QT interval and transmural dispersion of repolarization in children. Anesth-Analg 2005; 100:71-7
10. Kuenszberg E, Loeckinger A, Kleinsasser A, Lindner KH, Puehringer F, Hoermann C: Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur J Anaesthesiol 2000; 17:662-4
11. Paventi S, Santevecchi A, Ranieri R: Effects of sevoflurane versus propofol on QT interval. Minerva Anestesiol 2001; 67:637-40
12. Yildirim H, Adanir T, Atay A, Katircioglu K, Savaci S: The effects of sevoflurane, isoflurane and desflurane on QT interval of the ECG. Eur J Anaesthesiol 2004; 21:566-70
13. Yamada M, Hatakeyama N, Shibuya N, Momose Y, Yamazaki M: Mechanism of QT interval prolongation induced by sevoflurane in guinea pig ventricular myocyte. Masui 2003; 52:482-8
14. Shibata S, Ono K, Iijima T: Sevoflurane inhibition of the slowly activating delayed rectifier K+ current in guinea pig ventricular cells. J Pharmacol Sci 2004; 95:363-73
15. Nabauer M, Beuckelmann DJ, Uberfuhr P, Steinbeck G: Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 1996; 93:168-77
16. Dixon JE, Shi W, Wang H-S, McDonald C, Yu H, Wymore RS, Cohen IS, McKinnon D: Role of the Kv4.3 K+ channel in ventricular muscle: A molecular correlate for the transient outward current. Circ Res 1996; 79:659-68
17. Rampe D, Roy M-L, Dennis A, Brown AM: A mechanism for the proarrhythmic effects of cisapride (Propulsid): High affinity block of the human cardiac potassium channel HERG. FEBS Lett 1997; 417:28-32
18. Kang J, Wang L, Cai F, Rampe D: High affinity block of the HERG cardiac K+ channel by the neuroleptic pimozide. Eur J Pharmacol 2000; 392:137-40
19. Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D: Interactions of the 5-hydroxtryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther 2000; 295:614-20
20. Salata JJ, Jurkiewicz NK, Wallace AA, Stupienski RF, Guinosso PJ, Lynch JJ: Cardiac electrophysiological actions of the histamine H1-recptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 1995; 76:110-9
21. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ: Improved patch clamp techniques for high resolution current recording from cells and cell free membrane patches. Pflugers Arch 1981; 391:85-100
22. Kang J, Chen X-L, Wang H, Ji J, Reynolds W, Lim S, Hendrix J, Rampe D: Cardiac ion channel effects of tolterodine. J Pharmacol Exp Ther 2004; 308:935-40
23. Rithalia A, Hopkins PM, Harrison SM: The effects of halothane, isoflurane, and sevoflurane on Ca2+ current and transient outward K+ current in subendocardial and subepicardial myocytes from the rat left ventricle. Anesth Analg 2004; 99:1615-22
24. Kharasch ED, Karol MD, Lanni C, Sawchuk R: Clinical sevoflurane metabolism and disposition: I. Sevoflurane and metabolite pharmacokinetics. ANESTHESIOLOGY 1995; 82:1369-78
25. Park WK, Pancrazio JJ, Suh CK, Lynch C: Myocardial depressant effects of sevoflurane: Mechanical and electrophysiological actions in vitro. ANESTHESIOLOGY 1996; 84:1166-76
26. Weigt HU, Kwok W-M, Rehmert GC, Turner LA, Bosnjak ZJ: Voltage-dependent effects of volatile anesthetics on cardiac sodium current. Anesth Analg 1997; 84:285-93
27. Martin RL, McDermott JS, Salmen HJ, Palmatier J, Cox BF, Gintant GA: The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: Influence of multi-channel block. J Cardiovasc Pharmacol 2004; 43:369-79
28. Li J, Correa AM: Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane. ANESTHESIOLOGY 2002; 97:921-30
29. Yamada M, Hatakeyama N, Malykhina AP, Yamazaki M, Momose Y, Akbarali HI: The effects of sevoflurane and propofol on QT interval and heterologously expressed human ether-a-go-go related gene currents in Xenopus oocytes. Anesth Analg 2006; 102:98-103
30. Kirsch GE, Trepakova ES, Brimecombe JC, Sidach SS, Erickson HD, Kochan MC, Shyjka LM, Lacerda AE, Brown AM: Variability in the measurement of hERG potassium channel inhibition: Effects of temperature and stimulus pattern. J Pharmacol Toxicol Methods 2004; 50:93-101
31. Chen X, Yamakage M, Yamada Y, Tohse N, Namiki A: Inhibitory effects of volatile anesthetics on currents produced on heterologous expression of KvLQT1 and minK in Xenopus oocytes. Vasc Pharmacol 2002; 39:33-8
32. Inoue M, Imanaga I: Masking of A-type K+ channel in guinea pig cardiac cells by extracellular Ca2+. Am J Physiol 1993; 264:C1434-8
33. Beuckelmann DJ, Nabauer M, Erdmann E: Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993; 73:379-85
34. Bennett SR, Griffin SC: Sevoflurane versus isoflurane in patients undergoing valvular cardiac surgery. J Cardiothorac Vasc Anesth 2001; 15:175-8
35. Djaiani GN, Hall J, Pugh S, Peaston RT: Vital capacity inhalation induction with sevoflurane: An alternative to standard intravenous induction for patients undergoing cardiac surgery. J Cardiovasc Vasc Anesth 2001; 15:169-74
36. Story DA, Poustie S, Liu G, McNicol PL: Changes in plasma creatinine concentration after cardiac anesthesia with isoflurane, propofol, or sevoflurane: A randomized clinical trial. ANESTHESIOLOGY 2001; 95:842-8
37. Biliczki P, Virag L, Iost N, Papp JG, Varro A: Interactions of different potassium channels in cardiac repolarization in dog ventricular preparations: Role of repolarization reserve. Br J Pharmacol 2002; 137:361-8
38. Burashnikov A, Antzelevitch C: Prominent I(Ks) in epicardium and endocardium contributes to development of transmural dispersion of repolarization but protects against development of early afterdepolarizations. J Cardiovasc Electrophysiol 2002; 13:172-7
39. Kies SJ, Pabelick CM, Hurley HA, White RD, Ackerman MJ: Anesthesia for patients with congenital long QT syndrome. ANESTHESIOLOGY 2005; 102:204-10
40. Gallagher JD, Weindling SN, Anderson G, Fillinger MP: Effects of sevoflurane on QT interval in a patient with congenital long QT syndrome. ANESTHESIOLOGY 1998; 89:1569-73
41. Saussine M, Massad I, Raczka F, Davy J-M, Frapier J-M: Torsades de pointes during sevoflurane anesthesia in a child with congenital long QT syndrome. Paediatr Anaesth 2006; 16:63-5